Paradoxical Association of Postoperative Plasma Sphingosine-1-Phosphate with Breast Cancer Aggressiveness and Chemotherapy
Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator that has been shown to serve an important regulatory function in breast cancer progression. This study analyzes plasma S1P levels in breast cancer patients undergoing adjuvant therapy as compared to healthy control volunteers. 452 plasma S1...
Saved in:
Main Authors: | Rajesh Ramanathan, Ali Raza, Jamie Sturgill, Debra Lyon, Jessica Young, Nitai C. Hait, Kazuaki Takabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2017/5984819 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential
by: Masayo Aoki, et al.
Published: (2016-01-01) -
Corrigendum to “Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential”
by: Masayo Aoki, et al.
Published: (2016-01-01) -
Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer
by: Junko Tsuchida, et al.
Published: (2017-01-01) -
The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy
by: Lin Wang, et al.
Published: (2025-02-01) -
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
by: Huanyu Z. Li, et al.
Published: (2025-01-01)